Stent thrombosis: insights on outcomes, predictors and impact of dual antiplatelet therapy interruption from the SPIRIT II, SPIRIT III, SPIRIT IV and COMPARE trials
Authors:
- Gregg StoneGSGregg Stone
- Dean KereiakesDKDean Kereiakes
- Patrick SerruysPSPatrick Serruys
- Helen PariseHPHelen Parise
- Martin FahyMFMartin Fahy
- Charles SimontonCSCharles Simonton
- Krishnankutty SudhirKSKrishnankutty Sudhir
- Poornima SoodPSPoornima Sood
- Pieter SmitsPSPieter Smits
- 1 September 2012
- journal article
- research article
- Published by Europa Digital & Publishing in EuroIntervention
- Vol. 8 (5) , 599-606
Abstract
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)Keywords
This publication has 25 references indexed in Scilit:
- Differential Clinical Responses to Everolimus-Eluting and Paclitaxel-Eluting Coronary Stents in Patients With and Without Diabetes MellitusCirculation, 2011
- Predictors of death or myocardial infarction, ischaemic-driven revascularisation, and major adverse cardiovascular events following everolimus-eluting or paclitaxel-eluting stent deployment: pooled analysis from the SPIRIT II, III, IV and COMPARE trialsEuroIntervention, 2011
- Unrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers trialThe Lancet, 2011
- Comparison of Zotarolimus-Eluting and Everolimus-Eluting Coronary StentsNew England Journal of Medicine, 2010
- Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting StentsNew England Journal of Medicine, 2010
- Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery DiseaseNew England Journal of Medicine, 2009
- Randomized Comparison of Everolimus-Eluting and Paclitaxel-Eluting StentsCirculation, 2009
- Endothelial Cell Recovery Between Comparator Polymer-Based Drug-Eluting StentsJACC, 2008
- Clinical End Points in Coronary Stent TrialsCirculation, 2007
- Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic EventsNew England Journal of Medicine, 2006